Pregnancy Associated Atypical Hemolytic Uremic Syndrome Treated with Eculizumab
Author Information
Author(s): Gunawan Fery, Mangler Mandy, Sanders Cindy, Leonardo Trisha Ardine, Cindy Yosefina
Primary Institution: Department of Obstetric and Gynecology, Hospital Werner Forßmann, Eberswalde, Germany
Conclusion
Eculizumab treatment significantly improved the patient's condition after a diagnosis of pregnancy-associated atypical hemolytic uremic syndrome.
Supporting Evidence
- The patient was diagnosed with HELLP syndrome but later revealed to have p-aHUS.
- Eculizumab was administered after the diagnosis of p-aHUS.
- Clinical and laboratory signs improved after treatment with Eculizumab.
- The patient was discharged after 20 days with significantly improved condition.
Takeaway
A pregnant woman with a serious condition called p-aHUS was treated with a medicine called Eculizumab, which helped her get better after a difficult delivery.
Methodology
The patient was treated with Eculizumab after being diagnosed with p-aHUS following a Caesarean section.
Limitations
More studies are required to determine a standardized treatment regimen for p-aHUS.
Participant Demographics
32-year-old Caucasian woman, 38 weeks pregnant.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website